Allstar Health Brands Inc (ALST)

[sam1933]

Axxess Pharma Announces Financial Audits and Form S-1 to Be Filed With SEC Within One Week for Fully Reporting Status
Jul 17, 2014
OTC Disclosure & News Service

Toronto, ONT, Canada -

Management Now Preparing for Listing on the Over the Counter Bulletin Board (OTC: BB) Stock Exchange

TORONTO, ON--(Marketwired - Jul 17, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce that it has completed their PCAOB audited financial statements.

The completion of audited financials by Axxess Pharma Inc. is one more step in providing added transparency to all of the Company's shareholders. The filings will be available on the SEC website at such time as they commence filing with the SEC.

Management is now preparing to file their S-1 Registration Statement with the SEC to become a fully reporting Company and move to the OTC: BB. This listing will allow investors, stock brokers, wealth managers and Portfolio Managers to have improved tradability of the stock (ticker symbol: AXXE).

"This is another major accomplishment for our rapidly growing company. The completion of our audits and filing for fully reporting status on the OTC: BB listing, comes at a time when our sales are accelerating at a rapid pace, both month over month and year over year." said Dr. Daniel Bagi, President of Axxess Pharma Inc. "Our fully reporting status will allow shareholders to experience financial transparency of our company and help generate further liquidity in our stock. Our financial audits will soon be available for viewing on sec.gov as well our website: http://www.axxesspharmainc.com."; Dr. Daniel Bagi concluded.

About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements. To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, please visit: http://buytapoutme.com and http://www.tapoutmusclerecovery.com.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at [phone].

About TapouT: TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com.
https://www.facebook.com/TapouT
https://twitter.com/TapouT
http://www.youtube.com/tapout


Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks, estimated, expected, intended or projected. In each instance, forward-looking information should be and uncertainties.

Contact:

Investor Relations
Taylor Capitol, Inc.
Stephen Taylor
[phone]
[e-mail]
www.TheStockAlerts.com

Copyright © 2014 OTC Markets. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
http://www.otcmarkets.com/stock/AXXE/news/Axxess-Pharma-Announces-Financial-Audits-and-Form-S-1-to-Be-Filed-With-SEC-Within-One-Week-for-Fully-Reporting-Status?id=84611&b=y